| 2.90 Data as of 3:58pm ET |  0.00 / 0.00%Today’s Change | 1.25 Today|||52-Week Range 3.79 | +66.67% Year-to-Date |
| Previous close | 2.90 |
| Today’s open | 2.90 |
| Day’s range | 2.85 - 2.94 |
| Volume | 98,699 |
| Average volume (3 months) | 268,306 |
| Market cap | $203.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -72.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| ACTCAdvanced Cell Techno... | +0.00 | +0.14% |
| SLNCFSilence Therapeutics... | 0.00 | 0.00% |
| IMUCImmunoCellular Thera... | +0.02 | +0.79% |
| DYAXDyax Corp | +0.01 | +0.40% |
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | $4.7M |
| Net profit margin | -- |
Sector Industrial Services |
Industry Engineering & Construction |
Chairman, President, CEO & Chief Financial Officer Frank M. Reynolds, MBA |
Chief Science Officer Brian Hess |
Corporate headquarters Cambridge, Massachusetts |
.
